Evidence mapPaperPMID 22226255Full record

ReviewJournal of diabetes science and technology2011

Bringing the artificial pancreas home: telemedicine aspects.

Giordano Lanzola, Davide Capozzi, Nadia Serina, Lalo Magni, Riccardo Bellazzi

Abstract readReview
In one paragraph

Review in Journal of diabetes science and technology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. AP@home: The Artificial Pancreas Is Now at Home.Journal of diabetes science and technology · 2016
    Review
  3. A Review of Emerging Technologies for the Management of Diabetes Mellitus.IEEE transactions on bio-medical engineering · 2015
    Review
  4. Designing an artificial pancreas architecture: the AP@home experience.Medical & biological engineering & computing · 2015
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giordano LanzolaDipartimento di Informatica e Sistemistica, Università di Pavia, Pavia, Italy. giordano.lanzola@unipv.it
Davide Capozzi
Nadia Serina
Lalo Magni
Riccardo Bellazzi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design and implementation of telemedicine systems able to support the artificial pancreas need careful choices to cope with technological requirements while preserving performance and decision support capabilities. This article addresses the issue of designing a general architecture for the telemedicine components of an artificial pancreas and illustrates a viable solution that is able to deal with different use cases and is amenable to support mobile-health implementations. The goal is to enforce interoperability among the components of the architecture and guarantee maximum flexibility for the ensuing implementations. Thus, the design stresses modularity and separation of concerns along with adoption of clearly defined protocols for interconnecting the necessary components. This accounts for the implementation of integrated telemedicine systems suitable as short-term monitoring devices for supporting validation of closed-loop algorithms as well as devices meant to provide a lifelong tighter control on the patient state once the artificial pancreas has become the preferred treatment for patients with diabetes.

Indexed as

Pancreas, ArtificialDiabetes Mellitus, Type 1HumansHypoglycemic AgentsInsulinTelemedicineHypoglycemic AgentsInsulin

Identifiers

PMID22226255
PMCPMC3262704

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.